Progress in the management of gynecologic cancer: consensus summary statement.
Department of Gynecologic Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital, Boston, USA.
Stephen A
SA
Cannistra
Robert C
RC
Bast
Jonathan S
JS
Berek
Michael A
MA
Bookman
Christopher P
CP
Crum
Paul D
PD
DePriest
Judy E
JE
Garber
Wui-Jin
WJ
Koh
Maurie
M
Markman
William P
WP
McGuire
Peter G
PG
Rose
Eric K
EK
Rowinsky
Gordon J S
GJ
Rustin
Steven J
SJ
Skates
Paul A
PA
Vasey
Laura
L
King
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D002277:Carcinoma / Q000175:diagnosis / Q000628:therapy; D003131:Combined Modality Therapy / Q000639:trends; D000077143:Docetaxel; D015507:Drugs, Investigational / Q000008:administration & dosage; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D007263:Infusions, Parenteral; D007274:Injections, Intraperitoneal; D008403:Mass Screening / Q000379:methods*; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000628:therapy; D011237:Predictive Value of Tests; D043823:Taxoids / Q000008:administration & dosage; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000628:therapy
D001688:Biological Products; D015507:Drugs, Investigational; D009944:Organoplatinum Compounds; D043823:Taxoids; D000077143:Docetaxel